406 related articles for article (PubMed ID: 28439797)
1. Desmoid-Type Fibromatosis: Who, When, and How to Treat.
Martínez Trufero J; Pajares Bernad I; Torres Ramón I; Hernando Cubero J; Pazo Cid R
Curr Treat Options Oncol; 2017 May; 18(5):29. PubMed ID: 28439797
[TBL] [Abstract][Full Text] [Related]
2. Radiation-induced Sarcomas Occurring in Desmoid-type Fibromatosis Are Not Always Derived From the Primary Tumor.
Verschoor AJ; Cleton-Jansen AM; Wijers-Koster P; Coffin CM; Lazar AJ; Nout RA; Rubin BP; Gelderblom H; Bovée JV
Am J Surg Pathol; 2015 Dec; 39(12):1701-7. PubMed ID: 26414222
[TBL] [Abstract][Full Text] [Related]
3. Desmoid fibromatosis: is the current picture changing?
Pandrowala S; Jones RL; Gupta S; Gulia A
Future Oncol; 2021 Sep; 17(25):3397-3408. PubMed ID: 34227399
[TBL] [Abstract][Full Text] [Related]
4. Lower Rate of CTNNB1 Mutations and Higher Rate of APC Mutations in Desmoid Fibromatosis of the Breast: A Series of 134 Tumors.
Norkowski E; Masliah-Planchon J; Le Guellec S; Trassard M; Courrèges JB; Charron-Barra C; Terrier P; Bonvalot S; Coindre JM; Laé M
Am J Surg Pathol; 2020 Sep; 44(9):1266-1273. PubMed ID: 32590455
[TBL] [Abstract][Full Text] [Related]
5. Surgical versus non-surgical approach in primary desmoid-type fibromatosis patients: A nationwide prospective cohort from the French Sarcoma Group.
Penel N; Le Cesne A; Bonvalot S; Giraud A; Bompas E; Rios M; Salas S; Isambert N; Boudou-Rouquette P; Honore C; Italiano A; Ray-Coquard I; Piperno-Neumann S; Gouin F; Bertucci F; Ryckewaert T; Kurtz JE; Ducimetiere F; Coindre JM; Blay JY
Eur J Cancer; 2017 Sep; 83():125-131. PubMed ID: 28735069
[TBL] [Abstract][Full Text] [Related]
6. The Role of Radiation Therapy for Symptomatic Desmoid Tumors.
Looi WS; Indelicato DJ; Rutenberg MS
Curr Treat Options Oncol; 2021 Mar; 22(4):34. PubMed ID: 33649873
[TBL] [Abstract][Full Text] [Related]
7. Extra-abdominal desmoid fibromatosis: A review of management, current guidance and unanswered questions.
Eastley N; McCulloch T; Esler C; Hennig I; Fairbairn J; Gronchi A; Ashford R
Eur J Surg Oncol; 2016 Jul; 42(7):1071-83. PubMed ID: 26965303
[TBL] [Abstract][Full Text] [Related]
8. Sporadic desmoid-type fibromatosis: a stepwise approach to a non-metastasising neoplasm--a position paper from the Italian and the French Sarcoma Group.
Gronchi A; Colombo C; Le Péchoux C; Dei Tos AP; Le Cesne A; Marrari A; Penel N; Grignani G; Blay JY; Casali PG; Stoeckle E; Gherlinzoni F; Meeus P; Mussi C; Gouin F; Duffaud F; Fiore M; Bonvalot S;
Ann Oncol; 2014 Mar; 25(3):578-583. PubMed ID: 24325833
[TBL] [Abstract][Full Text] [Related]
9. Is mutation analysis of β-catenin useful for the diagnosis of desmoid-type fibromatosis? A systematic review.
Sakai T; Hamada S; Koike H; Shimizu K; Yoshida M; Nishida Y
Jpn J Clin Oncol; 2020 Sep; 50(9):1037-1042. PubMed ID: 32533146
[TBL] [Abstract][Full Text] [Related]
10. Adult desmoid tumors: biology, management and ongoing trials.
Penel N; Chibon F; Salas S
Curr Opin Oncol; 2017 Jul; 29(4):268-274. PubMed ID: 28489620
[TBL] [Abstract][Full Text] [Related]
11. Desmoid-Type Fibromatosis: Evolving Treatment Standards.
Fiore M; MacNeill A; Gronchi A; Colombo C
Surg Oncol Clin N Am; 2016 Oct; 25(4):803-26. PubMed ID: 27591500
[TBL] [Abstract][Full Text] [Related]
12. Tailored Beta-catenin mutational approach in extra-abdominal sporadic desmoid tumor patients without therapeutic intervention.
van Broekhoven DL; Grünhagenl DJ; van Dalen T; van Coevorden F; Bonenkamp HJ; Been LB; Bemelmans MH; Dijkstra SD; Colombo C; Gronchi A; Verhoef C
BMC Cancer; 2016 Aug; 16(1):686. PubMed ID: 27565718
[TBL] [Abstract][Full Text] [Related]
13. Desmoid tumors of the head and neck: a therapeutic challenge.
de Bree E; Zoras O; Hunt JL; Takes RP; Suárez C; Mendenhall WM; Hinni ML; Rodrigo JP; Shaha AR; Rinaldo A; Ferlito A; de Bree R
Head Neck; 2014 Oct; 36(10):1517-26. PubMed ID: 24421052
[TBL] [Abstract][Full Text] [Related]
14. The Evolving Management of Desmoid Fibromatosis.
Prendergast K; Kryeziu S; Crago AM
Surg Clin North Am; 2022 Aug; 102(4):667-677. PubMed ID: 35952695
[TBL] [Abstract][Full Text] [Related]
15. Correlation of CTNNB1 Mutation Status with Progression Arrest Rate in RECIST Progressive Desmoid-Type Fibromatosis Treated with Imatinib: Translational Research Results from a Phase 2 Study of the German Interdisciplinary Sarcoma Group (GISG-01).
Kasper B; Gruenwald V; Reichardt P; Bauer S; Hohenberger P; Haller F
Ann Surg Oncol; 2016 Jun; 23(6):1924-7. PubMed ID: 26861905
[TBL] [Abstract][Full Text] [Related]
16. Optimal therapy for desmoid tumors: current options and challenges for the future.
Al-Jazrawe M; Au M; Alman B
Expert Rev Anticancer Ther; 2015; 15(12):1443-58. PubMed ID: 26472625
[TBL] [Abstract][Full Text] [Related]
17. Functional analysis of young patients with desmoid-type fibromatosis: Initial surveillance does not jeopardize long term quality of life.
Duhil de Bénazé G; Vigan M; Corradini N; Minard-Colin V; Marie-Cardine A; Verite C; Defachelles AS; Thebaud E; Castex MP; Sirvent N; Bodet D; Mansuy L; Rome A; Petit A; Plantaz D; Jourdain A; Mary P; Carton M; Orbach D
Eur J Surg Oncol; 2020 Jul; 46(7):1294-1300. PubMed ID: 32173177
[TBL] [Abstract][Full Text] [Related]
18. What is the best front-line approach in patients with desmoid fibromatosis? - A retrospective analysis from a reference center.
Sobczuk P; Agnieszczak IM; Grycuk W; Czarnecka AM; Świtaj T; Koseła-Paterczyk H; Morysiński T; Zdzienicki M; Rutkowski P
Eur J Surg Oncol; 2021 Oct; 47(10):2602-2608. PubMed ID: 33994241
[TBL] [Abstract][Full Text] [Related]
19. Desmoid tumors and current status of management.
Hosalkar HS; Fox EJ; Delaney T; Torbert JT; Ogilvie CM; Lackman RD
Orthop Clin North Am; 2006 Jan; 37(1):53-63. PubMed ID: 16311111
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors influencing event-free survival and treatments in desmoid-type fibromatosis: analysis from a large institution.
Huang K; Wang CM; Chen JG; Du CY; Zhou Y; Shi YQ; Fu H
Am J Surg; 2014 Jun; 207(6):847-54. PubMed ID: 24119719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
